While working at the bedside of a small child who has myasthenia gravis, the therapist notices a new medication order prescribing glycopyrrolate for the control of secretions. The ordered dosage route is intramuscular and intravenous dosage is 5 mcg/kg every 3 to 4 hours. What should the therapist do at this time?

Question

Quizplus · Accepted Answer

The enteral dose for control of secretions in children is 40 to 100 mcg/kg three or four times daily. The intramuscular and intravenous dosage is 4 to 10 mcg/kg every 3 to 4 hours. Glycopyrrolate is also used to counter the muscarinic effects of neostigmine and pyridostigmine during reversal of neuromuscular blockade. Contraindications to glycopyrrolate are similar to other anticholinergics medications, including narrow-angle glaucoma, severe ulcerative colitis, tachycardia, paralytic ileus, and myasthenia gravis.

While Working at the Bedside of a Small Child Who